Oracea Soolantra Association in Participants With Severe Rosacea

PHASE4CompletedINTERVENTIONAL
Enrollment

273

Participants

Timeline

Start Date

July 5, 2017

Primary Completion Date

February 8, 2018

Study Completion Date

February 8, 2018

Conditions
Rosacea
Interventions
DRUG

Ivermectin 1% cream

Topical to the face, approximately one small pea size amount per facial region (right and left cheeks, forehead, chin, and nose) once a day for 12 weeks

DRUG

Doxycycline 40 mg MR (30 mg Immediate Release & 10 mg Delayed Release beads) capsules

1 Capsule once-daily for 12 weeks

OTHER

Oral placebo capsules

1 Capsule once-daily for 12 weeks

Trial Locations (21)

33486

Private practice, Boca Raton

40202

Private practice, Louisville

40241

Private practice, Louisville

68144

Private practice, Omaha

70001

Private Practice, Metairie

72916

Private Practice, Fort Smith

78660

Private practice, Pflugerville

89148

Private practice, Las Vegas

95819

Private practice, Sacramento

Unknown

Private practice, Markham

Private practice, Montreal

Private practice, Peterborough

Private practice, Richmond Hill

Private practice, Waterloo

Private practice, Budapest

University, Debrecen

Hospital, Miskolc

Private practice, Pécel

University, Pécs

University, Szeged

Private practice, Szolnok

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galderma R&D

INDUSTRY

NCT03075891 - Oracea Soolantra Association in Participants With Severe Rosacea | Biotech Hunter | Biotech Hunter